CG-719P (01/14)
Page 2 of 2
DOT/USCG PERIODIC DRUG TESTING FORM
PRIVACY ACT STATEMENT
Authority: 5 U.S.C. 301; 14 U.S.C. 632; 46 U.S.C. 2103, 7101, 7302, 7305, 7313, 7314, 7316, 7317, 7319, 7502, 7701, 8701, 8703, 9102; 46 C.F.R. 12.02; 49
C.F.R. 1.45, 1.46
Purpose: The principal purpose for which this information will be used is to determine domestic and international qualifications for the issuance of merchant
mariner credentials. This includes establishing eligibility of a merchant mariner's credential, duplicate credentials, or additional endorsements issued by the
Coast Guard and establishing and maintaining continuous records of the person's documentation transactions.
Routine Uses: The information will be used by authorized Coast Guard personnel with a need to know the information to determine whether an applicant is a
safe and suitable person who is capable of performing the duties of the Merchant Mariner. The information will not be shared outside of DHS except in
accordance with the provisions of DHS/USCG-030 Merchant Seamen's Records System of Records, 74 FR 30308 (June 25, 2009).
Disclosure: Furnishing this information (including your SSN) is voluntary; however, failure to furnish the requested information may result in non-issuance of
the requested credential.
An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a valid OMB control number.
The United States Coast Guard estimates that the average burden for this report is 5 minutes. You may submit any comments concerning the accuracy of this
burden estimate or any suggestions for reducing the burden to: Commanding Officer, U. S. Coast Guard National Maritime Center, 100 Forbes Drive,
Martinsburg, WV 25404 or Office of Management and Budget, Paperwork Reduction Project (1625-0040), Washington, DC 20503.
REQUIREMENTS
• A drug test is required for all transactions EXCEPT endorsements, documents of
continuity, duplicates, and STCW certificates.
• Only a DOT 5 Panel (SAMHSA 5 Panel, formerly NIDA 5), testing for Marijuana,
Cocaine, Opiates, Phencyclidine, and Amphetamines will be accepted.
OPTION I
PERIODIC TESTING PROGRAM
• A USCG drug test conducted within the past 185 days by a laboratory accredited by
Substance Abuse and Mental Health Services Administration (SAMHSA), Department
of Health and Human Services.
• COLLECTION of a urine sample may be conducted by an independent medical
facility, private physician or at an employer-designated site as long as the collection
agent meets the qualification requirements to be a collection agent given in Title 49
CFR Part 40.30. It is CRITICAL that the sample is sent to an accredited SAMHSA
laboratory for ANALYSIS or the drug test is invalid.
• The ORIGINAL results are required. A FACSIMILE is acceptable, if it is originated
from the Medical Review Officer (MRO) or the Service Agent assisting the mariner,
and sent directly from the office. The drug test result must be signed and dated by the
MRO or by a representative of the service agent who assisted you in meeting this
requirement.
OPTION II
RANDOM TESTING
EXAMPLE (From Mariner Employers): APPLICANT'S NAME/SSN has been subject to a
random testing program meeting the criteria of Title 46 CFR 16.230 for at least 60 days
during the previous 185 days and has not failed nor refused to participate in a chemical
test for dangerous drugs.
EXAMPLE (Active Duty Military/Military Sealift Command/N.O.A.A/Army Corps of
Engineers): APPLICANT'S NAME/SSN has been subject to a random testing program
with no subsequent positive drug test results during the remainder of the six month period.
OPTION III
PRE-EMPLOYMENT TESTING
• An ORIGINAL DATED letter on mariner employer stationary signed by a company
official, stating that you have passed a pre-employment chemical test for dangerous
drugs within the past 185 days.
EXAMPLE: APPLICANT'S NAME/SSN passed a chemical test for dangerous drugs,
required under Title 46 CFR 16.210 within the previous six months of the date of this letter
with no subsequent positive drug test results during the remainder of the six month period.